Additional file 1: of Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial

Abstract

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents*. (DOCX 49 kb